Annual report
3353.TEDINET S100QTLN
Period2022-03-01 → 2023-02-28
Filed2023-05-25
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 145
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥33.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥33.6bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales |
| Revenue | ¥31.6bn | 2020-03-01 → 2021-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥32.0bn | 2019-03-01 → 2020-02-29d | Cons. | Net sales (5-year summary) |
| Revenue | ¥31.2bn | 2018-03-01 → 2019-02-28d | Cons. | Net sales (5-year summary) |
| Operating income | ¥935m | 2022-03-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2021-03-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2020-03-01 → 2021-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2019-03-01 → 2020-02-29d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2018-03-01 → 2019-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2022-03-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2021-03-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥760m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥852m | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥835m | 2020-03-01 → 2021-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥802m | 2019-03-01 → 2020-02-29d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥712m | 2018-03-01 → 2019-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥773m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥869m | 2021-03-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥27.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥29.1bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥28.6bn | at 2021-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.2bn | at 2020-02-29d | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.2bn | at 2019-02-28d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥14.9bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥17.2bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥11.9bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥10.5bn | at 2021-02-28d | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2020-02-29d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.6bn | at 2019-02-28d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.0bn | at 2022-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.3bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2021-02-28d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2020-02-29d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.2bn | at 2019-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.3bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥516m | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥478m | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥216m | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.2bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥375m | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.4bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥65m | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥591m | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥475m | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥202.2 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥226.92 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥221.31 | 2020-03-01 → 2021-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥210.36 | 2019-03-01 → 2020-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥185.95 | 2018-03-01 → 2019-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,207.14 | at 2023-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,030.61 | at 2022-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,791.36 | at 2021-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,667.87 | at 2020-02-29d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,505.51 | at 2019-02-28d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 43.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.1% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.7% | at 2021-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2020-02-29d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.4% | at 2019-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.5% | 2022-03-01 → 2023-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2021-03-01 → 2022-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-03-01 → 2021-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2019-03-01 → 2020-02-29d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2018-03-01 → 2019-02-28d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,297 | at 2023-02-28 | Cons. | Number of employees |
| Employees | 1,325 | at 2022-02-28 | Cons. | Number of employees |
| Employees | 1,304 | at 2021-02-28d | Cons. | Number of employees |
| Employees | 1,187 | at 2020-02-29d | Cons. | Number of employees |
| Employees | 1,178 | at 2019-02-28d | Cons. | Number of employees |
| Revenue | ¥1.0bn | 2022-03-01 → 2023-02-28 | Standalone | Operating revenue1 |
| Revenue | ¥970m | 2021-03-01 → 2022-02-28 | Standalone | Operating revenue1 |
| Operating income | ¥491m | 2022-03-01 → 2023-02-28 | Standalone | Operating income |
| Operating income | ¥383m | 2021-03-01 → 2022-02-28 | Standalone | Operating income |
| Ordinary income | ¥592m | 2022-03-01 → 2023-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥432m | 2021-03-01 → 2022-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥319m | 2020-03-01 → 2021-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥492m | 2019-03-01 → 2020-02-29d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥697m | 2018-03-01 → 2019-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥613m | 2022-03-01 → 2023-02-28 | Standalone | Income before income taxes |
| Profit before tax | ¥461m | 2021-03-01 → 2022-02-28 | Standalone | Income before income taxes |
| Net income | ¥526m | 2022-03-01 → 2023-02-28 | Standalone | Profit loss |
| Net income | ¥397m | 2021-03-01 → 2022-02-28 | Standalone | Profit loss |
| Net income | ¥355m | 2020-03-01 → 2021-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥311m | 2019-03-01 → 2020-02-29d | Standalone | Net income loss (5-year summary) |
| Net income | ¥685m | 2018-03-01 → 2019-02-28d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥11.8bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥12.5bn | at 2022-02-28 | Standalone | Assets |
| Total assets | ¥12.5bn | at 2021-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2020-02-29d | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.0bn | at 2019-02-28d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2023-02-28 | Standalone | Liabilities |
| Total liabilities | ¥4.2bn | at 2022-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥8.6bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥8.3bn | at 2022-02-28 | Standalone | Net assets |
| Net assets / equity | ¥8.0bn | at 2021-02-28d | Standalone | Net assets |
| Net assets / equity | ¥8.2bn | at 2020-02-29d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.1bn | at 2019-02-28d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2023-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2022-02-28 | Standalone | Cash and deposits |
| EPS (basic) | ¥140.07 | 2022-03-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.69 | 2021-03-01 → 2022-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.22 | 2020-03-01 → 2021-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.56 | 2019-03-01 → 2020-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥178.92 | 2018-03-01 → 2019-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥40 | 2022-03-01 → 2023-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-03-01 → 2022-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2020-03-01 → 2021-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2019-03-01 → 2020-02-29d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2018-03-01 → 2019-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,293.7 | at 2023-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,196.84 | at 2022-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,131.98 | at 2021-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,143.92 | at 2020-02-29d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,112.94 | at 2019-02-28d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 73.2% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.3% | at 2022-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2021-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.9% | at 2020-02-29d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.3% | at 2019-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.2% | 2022-03-01 → 2023-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2021-03-01 → 2022-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2020-03-01 → 2021-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2019-03-01 → 2020-02-29d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2018-03-01 → 2019-02-28d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,070,000 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,070,000 | at 2022-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,035,000 | at 2021-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,035,000 | at 2020-02-29d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,035,000 | at 2019-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 25 | at 2023-02-28 | Standalone | Number of employees |
| Employees | 25 | at 2022-02-28 | Standalone | Number of employees |
| Employees | 25 | at 2021-02-28d | Standalone | Number of employees |
| Employees | 17 | at 2020-02-29d | Standalone | Number of employees |
| Employees | 481 | at 2019-02-28d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 83
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-03-01 → 2023-02-28 | ¥26m |
| Reconciling Itemsreconciling | depreciation | 2022-03-01 → 2023-02-28 | ¥34m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2023-02-28 | −¥1.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2023-02-28 | −¥1.0bn |
| Reconciling Itemsreconciling | segment assets | at 2023-02-28 | ¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2023-02-28 | −¥709m |
| Dispensing Pharmacyreportable segment | capex | 2022-03-01 → 2023-02-28 | ¥214m |
| Dispensing Pharmacyreportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥160m |
| Dispensing Pharmacyreportable segment | employees | at 2023-02-28 | 462 pure |
| Dispensing Pharmacyreportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥23.1bn |
| Dispensing Pharmacyreportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥23.1bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2023-02-28 | ¥7.8bn |
| Dispensing Pharmacyreportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥1.5bn |
| Health Carereportable segment | capex | 2022-03-01 → 2023-02-28 | ¥67m |
| Health Carereportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥389m |
| Health Carereportable segment | employees | at 2023-02-28 | 776 pure |
| Health Carereportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥7.7bn |
| Health Carereportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥7.7bn |
| Health Carereportable segment | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥600,000 |
| Health Carereportable segment | segment assets | at 2023-02-28 | ¥9.5bn |
| Health Carereportable segment | segment profit | 2022-03-01 → 2023-02-28 | −¥29m |
| Medical Products Wholesalereportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥12m |
| Medical Products Wholesalereportable segment | employees | at 2023-02-28 | 33 pure |
| Medical Products Wholesalereportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥3.9bn |
| Medical Products Wholesalereportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥2.9bn |
| Medical Products Wholesalereportable segment | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥998m |
| Medical Products Wholesalereportable segment | segment assets | at 2023-02-28 | ¥1.3bn |
| Medical Products Wholesalereportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥57m |
| Real Estatereportable segment | capex | 2022-03-01 → 2023-02-28 | ¥6m |
| Real Estatereportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥37m |
| Real Estatereportable segment | employees | at 2023-02-28 | 1 pure |
| Real Estatereportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥189m |
| Real Estatereportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥187m |
| Real Estatereportable segment | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥2m |
| Real Estatereportable segment | segment assets | at 2023-02-28 | ¥1.6bn |
| Real Estatereportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥125m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-03-01 → 2023-02-28 | ¥286m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-03-01 → 2023-02-28 | ¥598m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2023-02-28 | ¥34.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2023-02-28 | ¥33.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-02-28 | ¥20.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2023-02-28 | ¥1.6bn |
| Reconciling Itemsreconciling | capex | 2021-03-01 → 2022-02-28 | ¥153m |
| Reconciling Itemsreconciling | depreciation | 2021-03-01 → 2022-02-28 | ¥40m |
| Reconciling Itemsreconciling | revenue | 2021-03-01 → 2022-02-28 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-03-01 → 2022-02-28 | −¥1.1bn |
| Reconciling Itemsreconciling | segment assets | at 2022-02-28 | ¥8.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-03-01 → 2022-02-28 | −¥736m |
| Dispensing Pharmacyreportable segment | capex | 2021-03-01 → 2022-02-28 | ¥176m |
| Dispensing Pharmacyreportable segment | depreciation | 2021-03-01 → 2022-02-28 | ¥144m |
| Dispensing Pharmacyreportable segment | revenue | 2021-03-01 → 2022-02-28 | ¥22.7bn |
| Dispensing Pharmacyreportable segment | revenue external | 2021-03-01 → 2022-02-28 | ¥22.7bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2022-02-28 | ¥7.6bn |
| Dispensing Pharmacyreportable segment | segment profit | 2021-03-01 → 2022-02-28 | ¥1.5bn |
| Health Carereportable segment | capex | 2021-03-01 → 2022-02-28 | ¥33m |
| Health Carereportable segment | depreciation | 2021-03-01 → 2022-02-28 | ¥397m |
| Health Carereportable segment | revenue | 2021-03-01 → 2022-02-28 | ¥7.8bn |
| Health Carereportable segment | revenue external | 2021-03-01 → 2022-02-28 | ¥7.8bn |
| Health Carereportable segment | revenue intersegment | 2021-03-01 → 2022-02-28 | ¥600,000 |
| Health Carereportable segment | segment assets | at 2022-02-28 | ¥10.5bn |
| Health Carereportable segment | segment profit | 2021-03-01 → 2022-02-28 | ¥219m |
| Medical Products Wholesalereportable segment | capex | 2021-03-01 → 2022-02-28 | ¥8m |
| Medical Products Wholesalereportable segment | depreciation | 2021-03-01 → 2022-02-28 | ¥8m |
| Medical Products Wholesalereportable segment | revenue | 2021-03-01 → 2022-02-28 | ¥3.9bn |
| Medical Products Wholesalereportable segment | revenue external | 2021-03-01 → 2022-02-28 | ¥2.8bn |
| Medical Products Wholesalereportable segment | revenue intersegment | 2021-03-01 → 2022-02-28 | ¥1.1bn |
| Medical Products Wholesalereportable segment | segment assets | at 2022-02-28 | ¥1.3bn |
| Medical Products Wholesalereportable segment | segment profit | 2021-03-01 → 2022-02-28 | ¥114m |
| Real Estatereportable segment | depreciation | 2021-03-01 → 2022-02-28 | ¥40m |
| Real Estatereportable segment | revenue | 2021-03-01 → 2022-02-28 | ¥233m |
| Real Estatereportable segment | revenue external | 2021-03-01 → 2022-02-28 | ¥232m |
| Real Estatereportable segment | revenue intersegment | 2021-03-01 → 2022-02-28 | ¥2m |
| Real Estatereportable segment | segment assets | at 2022-02-28 | ¥1.7bn |
| Real Estatereportable segment | segment profit | 2021-03-01 → 2022-02-28 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-03-01 → 2022-02-28 | ¥216m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-03-01 → 2022-02-28 | ¥588m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-03-01 → 2022-02-28 | ¥34.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-03-01 → 2022-02-28 | ¥33.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-03-01 → 2022-02-28 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-02-28 | ¥21.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-03-01 → 2022-02-28 | ¥2.0bn |
| Real Estatereportable segment | employees | at 2023-02-28 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,435
| Item | Context | Value | Unit |
|---|---|---|---|
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 43475000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 40250000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 3225000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 9609000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 8730000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 879000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 13928000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 13050000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 878000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 4 | |
| Number of issues shares not listed investment shares held for pure investment largest holding company | CurrentYearInstant | － | |
| Book value equity securities not listed investment equity securities held for pure investment largest holding company | CurrentYearInstant | － | JPY |
| Number of issues shares not listed investment shares held for pure investment largest holding company | Prior1YearInstant | － | |
| Book value equity securities not listed investment equity securities held for pure investment largest holding company | Prior1YearInstant | － | JPY |
| Number of issues shares other than those not listed investment shares held for pure investment largest holding company | CurrentYearInstant | 46 | |
| Book value equity securities other than those not listed investment equity securities held for pure investment largest holding company | CurrentYearInstant | 1216078000 | JPY |
| Number of issues shares other than those not listed investment shares held for pure investment largest holding company | Prior1YearInstant | 41 | |
| Book value equity securities other than those not listed investment equity securities held for pure investment largest holding company | Prior1YearInstant | 994847000 | JPY |
| Total of dividends received equity securities not listed investment equity securities held for pure investment largest holding company | CurrentYearDuration | － | JPY |
| Total of gain loss on sale equity securities not listed investment equity securities held for pure investment largest holding company | CurrentYearDuration | － | JPY |
| Total of valuation gain loss equity securities not listed investment equity securities held for pure investment largest holding company | CurrentYearDuration | － | JPY |
| Total of dividends received equity securities other than those not listed investment equity securities held for pure investment largest holding company | CurrentYearDuration | 34868000 | JPY |
| Total of gain loss on sale equity securities other than those not listed investment equity securities held for pure investment largest holding company | CurrentYearDuration | 35229000 | JPY |
| Total of valuation gain loss equity securities other than those not listed investment equity securities held for pure investment largest holding company | CurrentYearDuration | － | JPY |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2 | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 92775000 | JPY |
| Number of issues whose number of shares increased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total acquisition cost for increased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares increased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 1 | |
| Total acquisition cost for increased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 13404000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 24293 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 21052 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 91584000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 96102000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 1000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 1000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 1191000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 1282000 | JPY |
| Cash and deposits | Prior1YearInstant | 7992461000 | JPY |
| Cash and deposits | CurrentYearInstant | 6443169000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 4890612000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 5009077000 | JPY |
| Merchandise | Prior1YearInstant | 1214011000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 22 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |